Clinical Integration of Next Generation Sequencing: A Policy Analysis

Mitchell A. , They See the Future and It Works for Them, New York Times, October 11, 1996.

Wetterstrand K. , DNA Sequencing Costs, National Human Genome Research Institute (2014), available at <http://www.genome.gov/sequencingcosts> (last visited July 9, 2014).

Schrijver I. Aziz N. and Farkas D. H. , Opportunities and Challenges Associated with Clinical Diagnostic Genome Sequencing: A Report of the Association for Molecular Pathology, Journal of Molecular Diagnostics 14, no. 6 (2012): 525–540.

Paxton A. , Next-Gen Shifts DNA Sequencing into Hyper-drive, CAP Today November, 2011, available at <http://www.cap.org/apps//cap.portal?_nfpb=truecntvwrPtlt_actionOverride=%2Fportlets%2FcontentViewer%2Fshow_windowLabel=cntvwrPtltcntvwrPtlt{actionForm.contentReference}=cap_today%2F1111%2F1111c_next_gen.html_state=maximized_pageLabel=cntvwr> (last visited July 9, 2014).

Saffitz J. E. , Genomic Pathology: A Disruptive Innovation, Personalized Medicine 9, no. 3 (2012): 237–239.

See Ma Q. C. Ennis C. A. and Aparicio S. , Opening Pandora's Box – The New Biology of Driver Mutations and Clonal Evolution in Cancer as Revealed by Next Generation Sequencing, Current Opinion in Genetics & Development 22, no. 1 (2012): 3–9 Calvo S. E. Compton A. G. and Hershman S. G. , Molecular Diagnosis of Infantile Mitochondrial Disease with Targeted Next-Generation Sequencing, Science Translational Medicine 4, no. 118 (2012): 118ra10, available at <http://stm.sciencemag.org/content/4/118/118ra10.full.pdf> (last visited August 26, 2014); Chiu R. W. Akolekar R. and Zheng Y. W. , Non-Invasive Prenatal Assessment of Trisomy 21 by Multiplexed Maternal Plasma DNA Sequencing: Large Scale Validity Study, British Medical Journal (Clinical Research ed.) 342 (2011): C7401, available at <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019239/pdf/bmj.c7401.pdf> (last visited August 26, 2014).

Moorthie S. Hall A. and Wright C. F. , Informatics and Clinical Genome Sequencing: Opening the Black Box, Genetics in Medicine 15, no. 3 (2013): 165–171.

Burke W. Antommaria A. H. M. and Bennett R. , Recommendations for Returning Genomic Incidental Findings? We Need to Talk! Genetics in Medicine 15, no. 11 (2013): 854–859; Green R. C. Berg J. S. and Grody W. W. , ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing, Genetics in Medicine 15, no. 7 (2013): 565–574.

Dewey F. E. Grove M. E. and Pan C. , Clinical Interpretation and Implications of Whole-Genome Sequencing, JAMA 311, no. 10 (2014): 1035–1044.

Gargis A. S. Kalman L. and Berry M. W. , Assuring the Quality of Next-Generation Sequencing in Clinical Laboratory Practice, Nature Biotechnology 30, no. 11 (2012): 1033–1036; see Federal Register 76 (May 19, 2011): 28990; Transcript, CDRH Public Meeting on Ultra High Throughput Sequencing for Clinical Diagnostic Applications – Approaches to Assess Analytical Validity (June 23, 2011), available at <http://www.fda.gov/downloads/MedicalDevices/NewsEvents/WorkshopsConferences/UCM266607.pdf> (last visited May 5, 2014); Walcoff S. D. and Pfeifer J. D. , Modernizing US Regulatory and Reimbursement Policy to Support Continued Innovation in Genomic Pathology, Personalized Medicine 9, no. 3 (2012): 295–308.

Ginsburg G. S. , Realizing the Opportunities of Genomics in Health Care, JAMA 309, no. 14 (2013): 1463–1464.

Javitt G. H. and Carner K. S. , Regulation of Next Generation Sequencing, Journal of Law, Medicine & Ethics 42, no. 3, Supp. (2014): 9–21.

Collins F. S. and Hamburg M. A. , First FDA Authorization for Next-Generation Sequencer, New England Journal of Medicine 369, no. 25 (2013): 2369–2371.

Deverka P. and Dreyfus J. C. , Clinical Integration of Next Generation Sequencing: Coverage and Reimbursement Challenges, Journal of Law, Medicine & Ethics 42, no. 3, Supp. (2014): 22–41.

Seesupra note 6.

BlueCross BlueShield of North Carolina, Corporate Medical Policy: Whole Exome Sequencing, November 2013, available at <https://www.bcbsnc.com/assets/services/public/pdfs/medicalpolicy/whole_exome_sequencing.pdf> (last visited July 9, 2014).

Cook-Deegan R. and Chandrasekharan S. , Patents and Genome-Wide DNA Sequence Analysis: Is It Safe to Go into the Human Genome? Journal of Law, Medicine & Ethics 42, no. 3, Supp. (2014): 42–50.

Evans B. J. , Economic Regulation of Next-Generation Sequencing, Journal of Law, Medicine & Ethics 42, no. 3, Supp. (2014): 51–66.

Id.

For full scope and methodology of this study, see Curnutte M. McGuire A. L. and Kaufman D. J. , Development of the Clinical NGS Industry in a Shifting Policy Climate, Nature Biotechnology (forthcoming, October 2014).

DNAnexus, Privacy, available at <https://www.dnanexus.com/privacy> (last visited July 9, 2014).